Jesús Rodríguez-Baño to Microbial Sensitivity Tests
This is a "connection" page, showing publications Jesús Rodríguez-Baño has written about Microbial Sensitivity Tests.
Connection Strength
0.608
-
Antibiotics for Ceftriaxone-Resistant Gram-Negative Bacterial Bloodstream Infections. JAMA. 2019 02 12; 321(6):612-613.
Score: 0.100
-
Combination therapy for bloodstream infections with carbapenemase-producing Enterobacteriaceae - Authors' reply. Lancet Infect Dis. 2017 10; 17(10):1020-1021.
Score: 0.091
-
MIC of amoxicillin/clavulanate according to CLSI and EUCAST: discrepancies and clinical impact in patients with bloodstream infections due to Enterobacteriaceae. J Antimicrob Chemother. 2017 05 01; 72(5):1478-1487.
Score: 0.088
-
Role of inoculum and mutant frequency on fosfomycin MIC discrepancies by agar dilution and broth microdilution methods in Enterobacteriaceae. Clin Microbiol Infect. 2017 May; 23(5):325-331.
Score: 0.086
-
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals. Clin Microbiol Infect. 2018 Oct; 24(10):1070-1076.
Score: 0.023
-
Prevalence of Aminoglycoside-Modifying Enzymes in Escherichia coli and Klebsiella pneumoniae Producing Extended Spectrum ß-Lactamases Collected in Two Multicenter Studies in Spain. Microb Drug Resist. 2018 May; 24(4):367-376.
Score: 0.023
-
Prevalence and transmission dynamics of Escherichia coli ST131 among contacts of infected community and hospitalized patients. Clin Microbiol Infect. 2018 Jun; 24(6):618-623.
Score: 0.023
-
Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems. Antimicrob Agents Chemother. 2017 08; 61(8).
Score: 0.022
-
Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to Enterobacteriaceae (SIMPLIFY): a study protocol for a multicentre, open-label, phase III randomised, controlled, non-inferiority clinical trial. BMJ Open. 2017 06 09; 7(6):e015439.
Score: 0.022
-
Response to Bile Salts in Clinical Strains of Acinetobacter baumannii Lacking the AdeABC Efflux Pump: Virulence Associated with Quorum Sensing. Front Cell Infect Microbiol. 2017; 7:143.
Score: 0.022
-
Molecular insights into fosfomycin resistance in Escherichia coli. J Antimicrob Chemother. 2017 05 01; 72(5):1303-1309.
Score: 0.022
-
EUropean prospective cohort study on Enterobacteriaceae showing REsistance to CArbapenems (EURECA): a protocol of a European multicentre observational study. BMJ Open. 2017 04 03; 7(4):e015365.
Score: 0.022
-
Overproduction of Outer Membrane Protein A by Acinetobacter baumannii as a Risk Factor for Nosocomial Pneumonia, Bacteremia, and Mortality Rate Increase. J Infect Dis. 2017 03 15; 215(6):966-974.
Score: 0.022
-
Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: the Bacteraemia-MIC project. J Antimicrob Chemother. 2016 Feb; 71(2):521-30.
Score: 0.020
-
[Consensus document for the treatment of bacteremia and endocarditis caused by methicillin-resistent Staphylococcus aureus. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica]. Enferm Infecc Microbiol Clin. 2009 Feb; 27(2):105-15.
Score: 0.012
-
[Epidemiology, clinical features and prognosis of infections due to Stenotrophomonas maltophilia]. Enferm Infecc Microbiol Clin. 2006 Jan; 24(1):4-9.
Score: 0.010